(Q44340697)

English

Chiral 3,3'-(1,2-ethanediyl)-bis[2-(3,4-dimethoxyphenyl)-4-thiazolidinones] with anti-inflammatory activity. Part 11: evaluation of COX-2 selectivity and modelling

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Chiral 3,3'-(1,2-ethanediyl)-bis[2-(3,4-dimethoxyphenyl)-4-thiazolidinones] with anti-inflammatory activity. Part 11: evaluation of COX-2 selectivity and modelling (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

0 references

1 reference

based on heuristic

inferred from title

Francesco Ortuso

11

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

author name string

M G Vigorita

1

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

R Ottanà

2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

F Monforte

3

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

R Maccari

4

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

M T Monforte

5

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

A Trovato

6

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

M F Taviano

7

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

N Miceli

8

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

G De Luca

9

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

S Alcaro

10

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

language of work or name

0 references

publication date

1 March 2003

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Bioorganic & Medicinal Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

999-1006

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Towards a better aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900518-7

7 January 2021

based on heuristic

inferred from DOI database lookup

COX-2 inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900518-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclo-oxygenase isoenzymes. How recent findings affect thinking about nonsteroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900518-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Structure of COX-1 and COX-2 enzymes and their interaction with inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900518-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclooxygenase-2 selective inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900518-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Ester and amide derivatives of the nonsteroidal antiinflammatory drug, indomethacin, as selective cyclooxygenase-2 inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900518-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Structure-based design of COX-2 selectivity into flurbiprofen

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900518-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiinflammatory 4,5-diarylpyrroles. 2. Activity as a function of cyclooxygenase-2 inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900518-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Design and synthesis of 4,5-diphenyl-4-isoxazolines: novel inhibitors of cyclooxygenase-2 with analgesic and antiinflammatory activity

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900518-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Design and synthesis of celecoxib and rofecoxib analogues as selective cyclooxygenase-2 (COX-2) inhibitors: replacement of sulfonamide and methylsulfonyl pharmacophores by an azido bioisostere

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900518-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib).

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900518-7

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900518-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The discovery of rofecoxib, [MK 966, Vioxx, 4-(4'-methylsulfonylphenyl)-3-phenyl-2(5H)-furanone], an orally active cyclooxygenase-2-inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900518-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical aspects of COX-2 inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900518-7

7 January 2021

based on heuristic

inferred from DOI database lookup

3,3′-Di [1,3-thiazolidine-4-one] system. VI. Structural and conformational studies on configurational isomers with antihistaminic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900518-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Synthesis and antiinflammatory, analgesic activity of 3,3'-(1,2-ethanediyl)-bis[2-aryl-4-thiazolidinone] chiral compounds. Part 10.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900518-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Reactions between nitric oxide, superoxide, and peroxynitrite: footprints of peroxynitrite in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900518-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900518-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900518-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonsteroidal anti-inflammatory drugs, COX-2 and colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900518-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900518-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative molecular modeling study of the three-dimensional structures of prostaglandin endoperoxide H2 synthase 1 and 2 (COX-1 and COX-2).

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900518-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A single amino acid difference between cyclooxygenase-1 (COX-1) and -2 (COX-2) reverses the selectivity of COX-2 specific inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900518-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanism of selective inhibition of the inducible isoform of prostaglandin G/H synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900518-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Modeling and biological evaluation of 3,3'-(1,2-ethanediyl)bis[2-(4-methoxyphenyl)-thiazolidin-4-one], a new synthetic cyclooxygenase-2 inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900518-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0968-0896(02)00518-7

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44340697&oldid=2109572507"